Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04035356Terminated

HAART Annuloplasty Device Valve Repair Registry

Role: lead

NCT02071849Not ApplicableCompleted

HAART 200 Aortic Valve Annuloplasty Trial

Role: lead

NCT01732835Not ApplicableCompleted

The HAART 300 Annuloplasty Ring Trial Extended Safety and Performance

Role: lead

NCT01400841Not ApplicableCompleted

HAART Model 300 Annuloplasty Ring

Role: lead

All 4 trials loaded